Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW Infants: a National Survey in China

NCT05372211 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.

NCT NCT05372211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05372211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW Infants: a National Survey in China
Lead sponsor
Shenzhen People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2022
Completion date
October 1, 2022
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

erythropoietin; infant; surveys and questionnaires